Item 6. Exhibits


Exhibit Number						Exhibit Name
3.1						Revvity, Inc.'s Restated Articles of Organization, as amended, attached hereto as Exhibit 3.1.
3.2						Revvity, Inc.'s Amended and Restated By-laws, attached hereto as Exhibit 3.2.
10.1						Credit Agreement, dated as of January 7, 2025, among Revvity, Inc. and Revvity Health Sciences, Inc. as Borrowers, Bank of America, N.A. as Administrative Agent, Swing Line Lender and an L/C Issuer, the Lenders party thereto and the other L/C Issuers party thereto, filed with the Commission on January 7, 2025 as Exhibit 99.1 to our current report on Form 8-K (File No. 001-05075) and herein incorporated by reference.
31.1						Certification of Chief Executive Officer pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2						Certification of Chief Financial Officer pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1						Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS						Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH						Inline XBRL Taxonomy Extension Schema Document.

101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB						Inline XBRL Taxonomy Extension Labels Linkbase Document.

101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104						Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101).

Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language):

(i) Cover Page, Form 10-Q, Quarterly Report for the quarterly period ended March 30, 2025 (ii) Condensed Consolidated Statements of Operations for the three months ended March 30, 2025 and March 31, 2024, (iii) Condensed Consolidated Statements of Comprehensive Income for the three months ended March 30, 2025 and March 31, 2024, (iv) Condensed Consolidated Balance Sheets at March 30, 2025 and December 29, 2024, (v) Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 30, 2025 and March 31, 2024, (vi) Condensed Consolidated Statements of Cash Flows for the three months ended March 30, 2025 and March 31, 2024, and (vii) Notes to Condensed Consolidated Financial Statements.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	REVVITY, INC.

May 6, 2025	By:	/s/ MAXWELL KRAKOWIAK
		Maxwell Krakowiak Senior Vice President and Chief Financial Officer (Principal Financial Officer)


	REVVITY, INC.

May 6, 2025	By:	/s/ ANITA GONZALES
		Anita Gonzales Vice President and Controller (Principal Accounting Officer)

Previous: Item 5. Other Information